3 ms·
> It is a racemic compound with two stereoisomers, the (S)-(–)-isomer being five times as pharmacologically active as the (R)-(+)-isomer.[14] I can't wait unti
by goodells 6y ago
> It is a racemic compound with two stereoisomers, the (S)-(–)-isomer being five times as pharmacologically active as the (R)-(+)-isomer.[14]
I can't wait until 2041 when this is phased out and we get "esviloxazine" for $300+/month.